It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Autophagy is a conserved, catabolic process essential for maintaining cellular homeostasis. Malfunctional autophagy contributes to neurodevelopmental and neurodegenerative diseases. However, the exact role and targets of autophagy in human neurons remain elusive. Here we report a systematic investigation of neuronal autophagy targets through integrated proteomics. Deep proteomic profiling of multiple autophagy-deficient lines of human induced neurons, mouse brains, and brain LC3-interactome reveals roles of neuronal autophagy in targeting proteins of multiple cellular organelles/pathways, including endoplasmic reticulum (ER), mitochondria, endosome, Golgi apparatus, synaptic vesicle (SV) for degradation. By combining phosphoproteomics and functional analysis in human and mouse neurons, we uncovered a function of neuronal autophagy in controlling cAMP-PKA and c-FOS-mediated neuronal activity through selective degradation of the protein kinase A - cAMP-binding regulatory (R)-subunit I (PKA-RI) complex. Lack of AKAP11 causes accumulation of the PKA-RI complex in the soma and neurites, demonstrating a constant clearance of PKA-RI complex through AKAP11-mediated degradation in neurons. Our study thus reveals the landscape of autophagy degradation in human neurons and identifies a physiological function of autophagy in controlling homeostasis of PKA-RI complex and specific PKA activity in neurons.
The health of brain cells is known to depend on functional autophagy, but the details are unclear. Here, the authors perform systematic proteomic profiling of human and mouse neurons, delineating the landscape of autophagy degradation in brain.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details










1 Icahn School of Medicine at Mount Sinai, Department of Neurology, The Friedman Brain Institute, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351); Icahn School of Medicine at Mount Sinai, Nash Family Department of Neuroscience, The Friedman Brain Institute, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351); Central South University, Department of Geriatrics, Xiangya Hospital, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164)
2 Icahn School of Medicine at Mount Sinai, Department of Neurology, The Friedman Brain Institute, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351); Icahn School of Medicine at Mount Sinai, Nash Family Department of Neuroscience, The Friedman Brain Institute, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351)
3 Icahn School of Medicine at Mount Sinai, Nash Family Department of Neuroscience, The Friedman Brain Institute, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351); Icahn School of Medicine at Mount Sinai, Institute for Regenerative Medicine, Alper Center for Neural Development and Regeneration, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351)
4 St. Jude Children’s Research Hospital, Department of Structural Biology, Memphis, USA (GRID:grid.240871.8) (ISNI:0000 0001 0224 711X); St. Jude Children’s Research Hospital, Department of Developmental Neurobiology, Memphis, USA (GRID:grid.240871.8) (ISNI:0000 0001 0224 711X); University of Tennessee Health Science Center, Integrated Biomedical Sciences Program, Memphis, USA (GRID:grid.267301.1) (ISNI:0000 0004 0386 9246)
5 St. Jude Children’s Research Hospital, Department of Structural Biology, Memphis, USA (GRID:grid.240871.8) (ISNI:0000 0001 0224 711X); St. Jude Children’s Research Hospital, Department of Developmental Neurobiology, Memphis, USA (GRID:grid.240871.8) (ISNI:0000 0001 0224 711X); St. Jude Children’s Research Hospital, Center for Proteomics and Metabolomics, Memphis, USA (GRID:grid.240871.8) (ISNI:0000 0001 0224 711X)
6 St. Jude Children’s Research Hospital, Center for Proteomics and Metabolomics, Memphis, USA (GRID:grid.240871.8) (ISNI:0000 0001 0224 711X)
7 Central South University, Department of Neurology, Xiangya Hospital, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164); Central South University, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164)
8 Icahn School of Medicine at Mount Sinai, Department of Neurology, The Friedman Brain Institute, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351); Icahn School of Medicine at Mount Sinai, Nash Family Department of Neuroscience, The Friedman Brain Institute, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351); Icahn School of Medicine at Mount Sinai, Center of Parkinson’s Disease Neurobiology, The Friedman Brain Institute, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351)